KT-621 (STAT6) parallel Phase 2b trials, BROADEN2 in atopic dermatitis and BREADTH in asthma, ongoing with data expected by mid-2027 and late 2027, respectively FDA granted Fast Track designation to ...
Discover 100 facts that will mess with your brain! Explore mind-bending truths about your body, animals, and history. Prepare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results